Comparative effectiveness of kilo- and megavoltage energies in low-dose radiotherapy for painful degenerative musculoskeletal diseases: a systematic review and meta-analysis
- PMID: 39633160
- PMCID: PMC12014772
- DOI: 10.1007/s00066-024-02329-0
Comparative effectiveness of kilo- and megavoltage energies in low-dose radiotherapy for painful degenerative musculoskeletal diseases: a systematic review and meta-analysis
Abstract
Purpose: This study aimed to assess the impact of different energy levels on the effectiveness of low-dose radiotherapy (LDRT) for treating painful degenerative musculoskeletal diseases, as comparative efficacy data are currently lacking.
Methods: A systematic review was conducted in PubMed, Embase, and the Cochrane Library databases to identify studies with response information on the energy used (kilovoltage [kV] vs. megavoltage [MV]). The primary endpoint was the overall response rate (ORR), and the secondary endpoint was the complete response rate (CRR). Exploratory subgroup analyses included treatment site, study period, study design, country, and dose per fraction.
Results: A total of 33 studies involving 12,143 patients were analyzed. Short-term follow-up (up to 6 months) showed a pooled ORR of 64% (95% CI 46-78%) for kV and of 62% (95% CI 54-70%) for MV. Long-term follow-up (at least 12 months) revealed a pooled ORR of 85% (95% CI 65-95%) for kV and of 69% (95% CI 62-75%) for MV. Subgroup analysis indicated no significant differences in ORR for energy level stratified by treatment site and other factors. Regarding dose per fraction (0.5 Gy vs. 1.0 Gy), comparable ORRs were demonstrated between the two energies. No clinical side effects were noted.
Conclusion: This meta-analysis suggests that the known effectiveness of LDRT in painful degenerative musculoskeletal disease may not depend on the energy used. Additional studies using standardized evaluation methods are warranted to establish consistency and enhance the comprehensiveness of research. Further research is also needed to explore treatment modality selection considering disease-specific biology.
Keywords: Chronic pain; Joint diseases; Low-dose; Osteoarthritis; Pain management; Radiotherapy.
© 2024. The Author(s).
Conflict of interest statement
Conflict of interest: A. Kim, J. Kwon, J.Y. Kim, and B.H. Kim declare that they have no competing interests.
Figures




References
-
- Micke O, Seegenschmiedt MH, Adamietz IA, Kundt G, Fakhrian K, Schaefer U et al (2017) Low-dose radiation therapy for benign painful skeletal disorders: the typical treatment for the elderly patient? Int J Radiat Oncol Biol Phys 98:958–963. 10.1016/j.ijrobp.2016.12.012 - PubMed
-
- Javadinia SA, Nazeminezhad N, Ghahramani-Asl R, Soroosh D, Fazilat-Panah D, PeyroShabany B et al (2021) Low-dose radiation therapy for osteoarthritis and enthesopathies: a review of current data. Int J Radiat Biol 97:1352–1367. 10.1080/09553002.2021.1956000 - PubMed
-
- Dove APH, Cmelak A, Darrow K, McComas KN, Chowdhary M, Beckta J et al (2022) The use of low-dose radiation therapy in osteoarthritis: a review. Int J Radiat Oncol Biol Phys 114:203–220. 10.1016/j.ijrobp.2022.04.029 - PubMed
-
- Reichl B, Block A, Schäfer U, Bert C, Müller R, Jung H et al (2015) DEGRO practical guidelines for radiotherapy of non-malignant disorders: part I: physical principles, radiobiological mechanisms, and radiogenic risk. Strahlenther Onkol 191:701–709. 10.1007/s00066-015-0865-8 - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources